• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性缺血性脑卒中的当代管理

Contemporary Management of Acute Ischemic Stroke.

作者信息

Ho James P, Powers William J

机构信息

Department of Neurology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.

Department of Neurology, Duke University School of Medicine, Durham, North Carolina, USA; email:

出版信息

Annu Rev Med. 2025 Jan;76(1):417-429. doi: 10.1146/annurev-med-050823-094312. Epub 2025 Jan 16.

DOI:10.1146/annurev-med-050823-094312
PMID:39496213
Abstract

In the past decade, adding mechanical thrombectomy (MT) of intracranial arterial occlusions to intravenous (IV) thrombolysis has revolutionized the treatment of acute ischemic stroke (AIS) by expanding the therapeutic window to 24 h. Treatment decisions require establishing a high probability of AIS; confirming time since last known well (LKW); assessing severity of the neurological deficit; determining any contraindications to IV thrombolysis; and performing neuroimaging, usually noncontrast computed tomography (NCCT), to exclude intracerebral hemorrhage. If time since LKW is less than 4.5 h, patients with disabling stroke without contraindications can proceed immediately to IV thrombolysis while the decision about MT is under way. For some patients, the MT decision can be made on the basis of clinical assessment, NCCT, and CT angiography showing a large vessel occlusion. Others may require additional neuroimaging. Patients who are not candidates for IV thrombolysis within 4.5 h or MT should be immediately evaluated for eligibility for extended-window IV thrombolysis or early antiplatelet treatment.

摘要

在过去十年中,将颅内动脉闭塞的机械取栓术(MT)与静脉溶栓(IV)相结合,通过将治疗窗口延长至24小时,彻底改变了急性缺血性卒中(AIS)的治疗方式。治疗决策需要确定AIS的高可能性;确认距最后已知正常状态(LKW)的时间;评估神经功能缺损的严重程度;确定IV溶栓的任何禁忌症;并进行神经影像学检查,通常是平扫计算机断层扫描(NCCT),以排除脑出血。如果距LKW的时间少于4.5小时,无禁忌症的致残性卒中患者可在进行MT决策的同时立即进行IV溶栓。对于一些患者,MT决策可基于临床评估、NCCT和显示大血管闭塞的CT血管造影做出。其他患者可能需要额外的神经影像学检查。在4.5小时内不适合IV溶栓或MT的患者应立即评估是否适合延长窗口IV溶栓或早期抗血小板治疗。

相似文献

1
Contemporary Management of Acute Ischemic Stroke.急性缺血性脑卒中的当代管理
Annu Rev Med. 2025 Jan;76(1):417-429. doi: 10.1146/annurev-med-050823-094312. Epub 2025 Jan 16.
2
Risk of Hemorrhagic Transformation after Mechanical Thrombectomy without versus with IV Thrombolysis for Acute Ischemic Stroke: A Systematic Review and Meta-analysis of Randomized Clinical Trials.机械取栓与静脉溶栓治疗急性缺血性脑卒中后出血性转化风险的比较:一项随机临床试验的系统评价和荟萃分析。
AJNR Am J Neuroradiol. 2024 Sep 9;45(9):1246-1252. doi: 10.3174/ajnr.A8307.
3
Diagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke: A Review.短暂性脑缺血发作和急性缺血性脑卒中的诊断与管理:综述。
JAMA. 2021 Mar 16;325(11):1088-1098. doi: 10.1001/jama.2020.26867.
4
Intravenous thrombolysis prior to mechanical thrombectomy does not affect clinical or procedural outcomes in patients with large vessel occlusion acute ischemic stroke.血管内溶栓治疗在前的机械取栓术并不影响大血管闭塞性急性缺血性脑卒中患者的临床或手术结局。
J Clin Neurosci. 2022 Jun;100:120-123. doi: 10.1016/j.jocn.2022.04.016. Epub 2022 Apr 19.
5
Intra-arterial thrombectomy versus standard intravenous thrombolysis in patients with anterior circulation stroke caused by intracranial arterial occlusions: a single-center experience.颅内动脉闭塞性前循环卒中患者动脉内取栓与标准静脉溶栓治疗的单中心经验
J Stroke Cerebrovasc Dis. 2013 Nov;22(8):e323-31. doi: 10.1016/j.jstrokecerebrovasdis.2013.01.001. Epub 2013 Feb 4.
6
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.急性缺血性脑卒中动脉内脑溶栓的试验设计与报告标准。
Stroke. 2003 Aug;34(8):e109-37. doi: 10.1161/01.STR.0000082721.62796.09. Epub 2003 Jul 17.
7
Assessment of Thrombectomy versus Combined Thrombolysis and Thrombectomy in Patients with Acute Ischemic Stroke and Medium Vessel Occlusion.急性缺血性脑卒中伴中等血管闭塞患者取栓术与溶栓联合取栓术的疗效评估。
Radiology. 2024 Aug;312(2):e233041. doi: 10.1148/radiol.233041.
8
The Efficacy and Safety of Tirofiban Use in Endovascular Thrombectomy for Intravenous Thrombolysis Applicable Patients with Large Vessel Occlusion Stroke-a Post Hoc Analysis from the Direct-MT Trial.替罗非班用于血管内血栓切除术治疗大血管闭塞性卒中静脉溶栓适用患者的疗效和安全性:来自 DIRECT-MT 试验的事后分析。
Cardiovasc Intervent Radiol. 2024 Feb;47(2):208-215. doi: 10.1007/s00270-023-03540-9. Epub 2023 Oct 5.
9
Endovascular Treatment of Thrombosis and Embolism.血栓形成和栓塞的血管内治疗
Adv Exp Med Biol. 2017;906:195-213. doi: 10.1007/5584_2016_116.
10
Hypoperfusion index ratio and pretreatment with intravenous thrombolysis are independent predictors of good functional outcome in acute ischemic stroke patients with large vessel occlusion treated with acute reperfusion therapies.低灌注指数比和静脉溶栓预处理是接受急性再灌注治疗的急性大血管闭塞性缺血性卒中患者良好功能预后的独立预测因素。
Neurol Sci. 2024 Oct;45(10):4881-4893. doi: 10.1007/s10072-024-07558-w. Epub 2024 May 18.

引用本文的文献

1
A Comprehensive Review of the Role of the Microbiota-Gut-Brain Axis via Neuroinflammation: Advances and Therapeutic Implications for Ischemic Stroke.通过神经炎症对微生物群-肠-脑轴作用的全面综述:缺血性中风的研究进展及治疗意义
Biomolecules. 2025 Jun 23;15(7):920. doi: 10.3390/biom15070920.
2
VISTA Alleviates Microglia-Mediated Neuroinflammation After Cerebral Ischemia-Reperfusion Injury via Regulating ACOD1/Itaconic Acid Metabolism.VISTA通过调节ACOD1/衣康酸代谢减轻脑缺血再灌注损伤后小胶质细胞介导的神经炎症。
Mol Neurobiol. 2025 Jun 19. doi: 10.1007/s12035-025-05106-x.
3
Risk Factors and Outcomes of Hemorrhagic Transformation in Acute Ischemic Stroke Following Thrombolysis: Analysis of a Single-Center Experience and Review of the Literature.
溶栓后急性缺血性卒中出血转化的危险因素及预后:单中心经验分析与文献综述
Medicina (Kaunas). 2025 Apr 14;61(4):722. doi: 10.3390/medicina61040722.
4
[Specialty-specific knowledge as prerequisite for effective treatment of critically ill patients].[专业特定知识是有效治疗重症患者的先决条件]
Chirurgie (Heidelb). 2025 Jun;96(6):504-513. doi: 10.1007/s00104-025-02286-z. Epub 2025 Apr 25.